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doi:10.1016/j.jmii.2011.04.012Background: Group A streptococcus (GAS) is a common cause of soft tissue infection. Nonste-
roidal anti-inflammatory drugs have been reported to worsen GAS soft tissue infections.
Methods: A mouse model of GAS soft tissue infection was developed. The extent of cutaneous
lesions, tissue damage, release of inflammatory cytokines, and survival rates were compared
between mice with and without ibuprofen administration after GAS soft tissue infection.
Results: All twelve mice without ibuprofen administration survived for at least 10 days. In
contrast, mortality rate of 14 mice with ibuprofen therapy was 72.5%. Ibuprofen-treated mice
exhibited more evident macrophage infiltration and tissue damage in the GAS-infected soft
tissues. In GAS-infected mice, tissue levels of interleukin 6 and tumor necrosis factor alpha
were significantly higher in ibuprofen-treated mice than those in the control group.
Conclusions: The results supported the concept that ibuprofen use in GAS soft tissue infections
might induce the development of severe necrotizing infections and increase mortality rate.
Copyright ª 2011, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Group A streptococcus (GAS), Streptococcus pyogenes, is
one of the most common pathogens of soft tissue infections.nt of Infectious Diseases,
g-Hwa Road, Yung-Kang City,
ei.org.tw (H.-J. Tang).
an Society of Microbiology. PublAbout 5e10 % of GAS soft tissue infections might evolve to
necrotizing fasciitis (NF). Of note, the associated mortality
rates of such invasive GAS infections ranged from 20% to
50%.1,2 Underlying comorbidities were predisposing factors
of NF caused by GAS infections.3
Use of nonsteroidal anti-inflammatory drugs (NSAIDs) is a
common clinical practice because doctors would prescribe
those drugs as analgesics or antipyretics to relieve suffer-
ings in patients with soft tissue infections. NSAID use is
common in clinical practice as an analgesic or antipyretic
for symptomatic relief in patients with soft tissueished by Elsevier Taiwan LLC. All rights reserved.
Ibuprofen worsens GAS cellulitis in mice 419infections. Recently, it has been reported that NSAIDs use
may worsen the severity of GAS infections, even in previ-
ously healthy patients.4e6 In some studies involving pedi-
atric population, the use of NSAIDs in those with varicella-
zoster virus infections has been associated with an
increased risk of invasive GAS infections.7,8 In addition,
NSAIDs had been considered to be involved in the patho-
genesis of streptococcal and staphylococcal toxic shock
syndrome, which posed high mortality rates in the affected
individuals.9 However, previous observational studies were
inconclusive regarding whether NSAIDs were a risk factor for
NF.2e4 Those studies were limited by small sample sizes,
retrospective characteristics, and the lack of a control
group. In particular, the existence of “indication bias,”
which suggests that NSAID may be given as a response to
infectious diseases in patients with severe soft tissue
infections, rather than being a cause of the severity of
illness, appeared in many studies.5e7
The exact role of NSAIDs in disease progression of GAS
infections is not clearly understood. Several authors have
proposed that the use of NSAIDs could prevent GAS infec-
tions if GAS infections were diagnosed early, or on the
contrary, would accelerate the infectious course as a result
of their suppressive effects on host immune response.10e12
In addition, a rabbit model examining the role of NSAIDs in
GAS soft tissue infections did not find the evidence that
NSAIDs would adversely affect the course.13 In our study,
we intended to establish a murine model of GAS soft tissue
infection and to examine the effect of ibuprofen in mice
with GAS soft tissue infections.
Materials and methods
Animals and bacterial strains
Six to 10 week-old female BALB/cByJ mice weighing
18e22 g were obtained from National Laboratory Animal
Center. Animals were housed in a pathogen-free environ-
ment using 12 hours alternating periods of light and dark
until the initiation of experiments. The study protocol was
approved by the Institutional Animal Care and Use
Committee of Chi Mei Medical Center, Taiwan.
Three clinical bacteremic isolates of S pyogenes (GAS-
13, GAS-19, GAS-Jack) from patients with NF and septic
arthritis were obtained from the microbiological laboratory
in Chi-Mei Medical Center. The organisms were stored at
70C in protected bacterial preservers (Technical Service
Consultants, Heywood, UK). Each S pyogenes isolate was
first cultured in Luria-Bertani broth (Difco Laboratories,
Detroit, MI, USA) and then on nutrient agar (Difco) at 37C
overnight. A single colony was chosen and cultured
overnight in freshly prepared Mueller-Hinton broth at 37C.
Four hundred microliters of each bacterial suspension was
individually added to 20 mL Mueller-Hinton broth and
incubated at 37C for 4 hours. Bacteria were collected by
centrifugation at 6,000 revolutions per minute for 10
minutes at 22C. Pellets were resuspended and diluted to
a final bacterial concentration of 2 109 colony forming
units (CFU)/mL before injection into the mice. The
concentration of the inoculum was confirmed by subse-
quent growth on agar plates.Murine model of GAS soft tissue infections and
ibuprofen therapy
To correlate the effects of drug exposure between mouse
and human, the dose in mice is equal to human doses
multiplied by human Km/mice,15,16 and therefore the
ibuprofen dose of 30 mg/kg/d in human, the usual dosage
for pain and fever control,14 is about 50 mg/kg/d in mice.
GAS strains (GAS-13, GAS-19, or GAS-Jack) were intramus-
cularly injected into right thigh of 26 mice with the inoc-
ulum of 108 CFU. To determine the effect of ibuprofen in
the course of GAS soft tissue infection, 14 of 26 mice were
treated with ibuprofen, and the other 12 with saline
(control group). After GAS infection, ibuprofen (Sigma-
Aldrich, St. Louis, MO, USA) dissolved in saline was orally
fed through an oral tube at a dose of 50 mg/kg/d divided
into three doses for 7 days.
Measurement of infected areas
Wound surface areas were measured daily from Day 1 to
Day 10. Images obtained by a Lumix DMC-FX9 digital camera
(Panasonic, Tokyo, Japan) were analyzed by the Image-
Proplus 5.0 software (Media Cyberbetics, Bethesda, MD,
USA). Wound areas tracing the wound margins with a fine
resolution computer mouse were calculated. Measurements
were performed in duplicate, and mean values of consec-
utive tracings were computed.
Histopathology of the infected lesions
At 7 days after injection of S pyogenes, mice were eutha-
nized with isoflurane, and infected tissues were obtained
from each animal via skin biopsies that included dermis and
underlying soft tissues. Each tissue sample was fixed in 10%
buffered formalin before embedding in paraffin. Formalin-
fixed tissues were sectioned and stained with hematoxylin
and eosin stain (Sigma-Aldrich) by standard methodology.
An Olympus model BX51 microscope equipped with a Q-FIRE
camera (Olympus, Tokyo, Japan) was used for image
capture.
Serum and tissue levels of interleukin 6 and tumor
necrosis factor alpha
The concentrations of tumor necrosis factor alpha (TNF-a)
and interleukin 6 (IL-6) in the serum and infected tissue
were determined. Two cytokines were measured on 1, 3, 5,
and 7 days after intramuscular inoculation of GAS using
commercial enzyme-linked immunosorbent assay kits (R&D
Systems, Minneapolis, MN, USA), according to the manu-
facturer’s instructions. These assays were performed in
duplicate.
Statistical analyses
Continuous variables were described as medians (inter-
quartile ranges) and compared by a Mann-Whitney U test
because of the small sample sizes. Survival curves were
determined by Kaplan-Meier survival analysis, and the
Figure 1. Wound size of ibuprofen-treated and control mice at Day 5. (A) The ibuprofen-treated wound extended to the other
side of the thigh with a dark-red discharge, with gangrene and necrotic discharge evident at the wound margin. (B) The control
mice show pink color and scar formation.
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15.0 software (SPSS, Inc., Chicago, IL, USA) was used for the
analysis. All statistical assessments were two sided, and a
p value less than 0.05 was considered to be statistically
significant.
Results
Adverse effect of ibuprofen in GAS soft tissue
infections
At Day 2 of GAS infection, the extent of lesions and
production of exudates were greater in mice treated with
ibuprofen than the control group (Figs. 1 and 2). Of note,
ibuprofen was discontinued on Day 7 in the experimental
group, and thereafter the wounds of the surviving mice
begun to heal. Thirteen days later, the wounds completely
healed with residual scars. In the control group, the time of
wound healing ranged from 3 days to 7 days (median 5Figure 2. Wound areas in ibuprofen-treated and control mice
ibuprofen-treated and control mice (control) was 1.76 cm2 at Da
anti-inflammatory drug.days), which was significantly shorter than those in the
mice treated with ibuprofen (median 8 days) (p< 0.001).
During the study period of 10 days, mice with GAS
infection receiving ibuprofen treatment had a higher
mortality rate than those without ibuprofen treatment
(Fig. 3). Of 14 mice treated with ibuprofen, 10 (72.5%) died
within 10 days, and in contrast, all 12 mice in the control
group survived (p< 0.001). In addition, ibuprofen-treated
mice were less active and had less appetite than those
without ibuprofen treatment.
Ibuprofen predisposed GAS NF
Inflammatory changes were significant in the muscle tissues
of ibuprofen-treated mice. Microscopic examinations
revealed that macrophage infiltration and swelling of
subcutaneous and muscle tissues were much more severe in
ibuprofen-treated mice (Fig. 4). In addition, there were
complete dissolution of the dermis and fascia and poly-
morphonuclear infiltration and numerous bacteria withinwithin 17 days after infection. The maximum wound area in
y 6 and 0.6 cm2 at Day 5, respectively. NSAIDZ nonsteroidal
Figure 3. Kaplan-Meier survival analysis of GAS infections in
control and ibuprofen-treated mice. At Day 10, survival rate of
the control mice was 100%, whereas that of the ibuprofen-
treated group was 27.5% (p< 0.001). As indicated by the bar,
ibuprofen use was discontinued at Day 7. GASZ group A
streptococcus.
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control group, there were minimal tissue damage and few
bacteria in the subcutaneous tissue (Fig. 4B). At Day 5, the
resected tissue was submitted for culture; and in the
ibuprofen-treated mice, GAS grew with a bacterial load of
2.47 108 CFU/g, which was 100-fold higher than that in
the control group.
Ibuprofen potentiates the release of
proinflammatory cytokines
The kinetics of tissue IL-6 levels was demonstrated in
Fig. 5A. The level of IL-6 in infected tissue is significantly
higher in the ibuprofen-treated group (pZ 0.0001)
(Fig. 5B). Tissue IL-6 peaked at Day 3 and declined gradu-
ally. Similarly, in the ibuprofen-treated mice, serum IL-6
level was higher (p< 0.0001). Peak serum level of IL-6
was noted at Day 3 and undetectable at Day 5. In the
control group, serum IL-6 level is undetectable at Day 3.
The levels of TNF-a in the infected tissue of ibuprofen-
treated mice were higher than those of mice without
ibuprofen treatment (pZ 0.001) (Fig. 5C). Tissue TNF-a
levels in two groups peaked at Day 1 and decreasedFigure 4. Pathological findings of infected soft tissues in ibuprof
and histiocytic infiltrates and tissue necrosis in muscle tissue of ibu
(B) Intact fascia and muscle tissue structures with minimal neutro
noted in infected mice without ibuprofen therapy (HE stain; 100gradually. At Day 3, tissue TNF-a level in the ibuprofen-
treated mice is 2.5-fold higher than that in the control
group. However, serum TNF-a level was undetectable in
two groups at the first day of GAS infection.
Discussion
The murine model established in the present study showed
that NSAIDs would worsen the GAS soft tissue infection,
which was compatible with previous clinical observations.
Several mechanisms may explain this phenomenon. One
hypothesis is that NSAIDs have adverse influences by sup-
pressing primitive functions of chemotaxis, oxidative burst,
phagocytosis, and bacterial killing in granulocytes.12 Data
also demonstrate that NSAIDs may inhibit neutrophil
aggregation or degranulation in vitro and in vivo, and so
interfere with the function of lymphocytes and inhibit
monocyte superoxide production.17,18 Moreover, some
studies provide the evidence that NSAIDs can augment
production of certain cytokines, such as TNF-a, IL-1, and
IL-6, on infection,12 which were similar to our findings in
the mice. Our findings were of clinical importance and we
suggest that frequent use of NSAIDs in patients with soft
tissue infection should be cautious, at least in those with
GAS infection. In addition, our study also provided the
model for further research to understand the effects of
NSAIDs on bacterial soft tissue infections.
The present study demonstrated that NSAIDs increased
the mortality significantly in the GAS-infected mice. These
findings can also be explained by the suppression of
immune function of granulocytes and upsurge of proin-
flammatory cytokines mediated by NSAIDs. Previous studies
indicate that an increase of proinflammatory cytokines
predispose patients to severe sepsis.19 Moreover, some
clinical evidences show that use of NSAIDs in patients with
GAS infection would possibly increase the risk of septic
shock and multiorgan failure,12,20 which leads to high
mortality subsequently. In the present study, levels of
TNF-a and IL-6 in the serum and infected tissue of mice
treated with ibuprofen peaked after the third day of GAS
infection, which were compatible with the finding that an
increase of mortality and wound necrosis had been notified
after that time.en-treated and control mice on Day 7. (A) Marked neutrophilic
profen-treated mice [hematoxylin and eosin (HE) stain; 100].
phil infiltration and few bacteria in subcutaneous tissue were
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Figure 5. Dynamics of serum and tissue levels of IL-6 and
TNF-a in mice with GAS infection with and without ibuprofen
therapy: (A) Tissue IL-6; (B) Serum IL-6; (C) Tissue TNF-a.
GASZ group A streptococcus; IL-6Z interleukin 6; TNF-
aZ tumor necrosis factor alpha.
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However, animal studies focus on the role of NSAIDs in
modulating the infection process is rare. GAS NF in a rabbit
model suggest that NSAIDs do not adversely affect the
outcome.17 Nonetheless, the rabbit model has some limi-
tations. The rabbits do not have muscular fascia. In addi-
tion, GAS is not naturally pathogenic to rabbits as in
humans. The picture similar to NF in humans has only been
seen in rabbits injected with the combination of GAS as wellas staphylococcal alpha toxin.13 Additionally, the inconsis-
tencies between previous studies and our results may be
explained by the different NSAID regimen. In our study,
ibuprofen (3 mg/kg body weight) was administered three
times per day orally consecutively for 7 days. In contrast,
two doses of NSAIDs (diclofenac 4 mg/kg body weight)
intramuscularly before and after GAS infection was
administrated in the rabbit model.21 Therefore, the current
model has a potential to become a template to study the
nature of NSAIDs in the infection process of GAS NF. More-
over, it merits further study to reveal the negative effects
of NSAIDs in soft tissue infections caused by pathogens
other than GAS, such Gram-negative organisms or Staphy-
lococcus aureus.
Although the effect of NSAIDs in human GAS infections
remains unclear, the present data suggest that the use of
NSAIDs predisposes affected patients to NF and subse-
quently increases mortality. Therefore, clinical use of
NSAIDs as analgesics or antipyretics in patients with skin
and soft tissue infection should be used with caution.References
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